As concerns around knockoffs of newer GLP-1 drugs like Ozempic and Wegovy take center stage, Novo Nordisk’s efforts to ward off competition against its aging diabetes blockbuster Victoza have ...

THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of ...

Liraglutide, sold under the brand name Victoza for diabetes ... But, Krumholz noted, the newer GLP-1 drugs, which are given as weekly injections instead of daily ones, have shown stronger benefits ...

Liraglutide (Victoza, Saxenda) -- another GLP-1 indicated for diabetes and weight management -- did not have this same signal, according to Georgios Schoretsanitis, MD, PhD, of Zucker Hillside ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), significantly improving access to diabetes treatment. The glucagon-like peptide-1 ...

China represents an untapped market for GLP-1 class diabetes drugs, according to Novo Nordisk, which is predicting "good momentum" for its already-approved Victoza, and its successor semaglutide.

Half of the websites (49.4%) failed to mention risks including adverse effects, warnings and precautions, and ...

Teva Pharmaceuticals also offers a generic form of Victoza, a GLP-1 drug first approved for Type 2 diabetes in 2010. 3. Cost issues GLP-1 list prices are about $1,000 for a four-week supply ...

The FDA approved Hikma's first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic ...